Cardiovascular Systems press release (CSII): Q4 GAAP EPS of -$0.25 misses by $0.03.Revenue of $62.5M (-12.0% Y/Y) misses by $0.46M.The Adjusted EBITDA loss increased to $4.3M from...
- Cardiovascular Systems press release (NASDAQ:CSII): Q4 GAAP EPS of -$0.25 misses by $0.03.
- Revenue of $62.5M (-12.0% Y/Y) misses by $0.46M.
- The Adjusted EBITDA loss increased to $4.3M from near breakeven in the prior year.
For the fiscal year ending June 30, 2023, CSI anticipates: Revenue of $255 million to $265 million vs. consensus of $261.3M, representing 8% to 12% growth compared to fiscal 22; Gross profit as a percentage of approximately 72% to 74% of revenues; Research and development expenses will be approximately 16% to 17% of revenues; Net loss in a range of 9% to 11% of revenues; and Adjusted EBITDA near break-even.
Comments
0 comment